The company
Labcorp Holdings Inc.
LH · NYSE
Health CareDiagnostics & LabsLeading
LH stood above a rising 150-day average in 28 of the last 52 weekly readings, including each of the last 17 weeks. It is 10.7% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 17 in a row
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $24.1M
- Officials’ trades on record
- 54
- Institutions holding
- 979 (+21)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
17 Apr – 16 Oct
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars.
Congress and officials
54 disclosed lines: House 46, Senate 6, executive 2; 17 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| April McClain Delaney House: U.S. House ClerkMD06 | solddependent child | $100k–$250k | 25 Aug 2026filed 9 Sep 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | solddependent child | $1k–$15k | 7 Aug 2026filed 9 Sep 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | solddependent child | $1k–$15k | 6 Aug 2026filed 9 Sep 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | solddependent child | $1k–$15k | 5 Aug 2026filed 9 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 11 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 10 Apr 2026filed 1 Jul 2026 |
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 27 Mar 2026filed 21 Jul 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | boughtdependent child | $1k–$15k | 11 Feb 2026filed 10 Mar 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | boughtdependent child | $1k–$15k | 4 Feb 2026filed 10 Mar 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | boughtdependent child | $1k–$15k | 28 Jan 2026filed 2 Feb 2026 |
| April McClain Delaney House: U.S. House ClerkMD06 | boughtdependent child | $1k–$15k | 17 Nov 2025filed 8 Dec 2025 |
| April McClain Delaney House: U.S. House ClerkMD06 | boughtdependent child | $1k–$15k | 31 Oct 2025filed 4 Nov 2025 |
Insiders
Buy orders, 12 months0
Sale orders, 12 months20
Buyers · sellers0 · 10
| Who | Did | Shares | Traded |
|---|---|---|---|
| Kerrii B. AndersonDirector | sold | 3,000at $318.02 | 17 Aug 2026filed 18 Aug 2026 |
| Adam H. SchechterPresident & CEO | sold | 4,669at $320.37 | 11 Aug 2026filed 12 Aug 2026 |
| Amy B. SummyEVP, Chief Marketing Officer | sold | 924at $306.74 | 4 Aug 2026filed 6 Aug 2026 |
| Peter J. WilkinsonSVP, Chief Accounting Officer | sold | 82at $309.22 | 3 Aug 2026filed 5 Aug 2026 |
| Peter J. WilkinsonSVP, Chief Accounting Officer | sold | 1,338at $309.23 | 3 Aug 2026filed 5 Aug 2026 |
| Bryan T. VaughnEVP and President, Diagnostics | sold | 234at $286.19 | 2 Jul 2026filed 6 Jul 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | sold | 92at $286.19 | 2 Jul 2026filed 6 Jul 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | sold | 762at $263.89 | 8 Jun 2026filed 10 Jun 2026 |
| Adam H. SchechterPresident & CEO | sold | 5,903at $254.50 | 11 May 2026filed 13 May 2026 |
| Jonathan C. MeltzerEVP, Operations | sold | 839at $267.05 | 27 Mar 2026filed 30 Mar 2026 |
| Peter J. WilkinsonSVP, Chief Accounting Officer | sold | 1,633at $267.05 | 27 Mar 2026filed 30 Mar 2026 |
| Adam H. SchechterPresident & CEO | sold | 8,705at $279.96 | 3 Mar 2026filed 5 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Holders979+21 on the quarter
New · exited105 · 85
Reported value$21.2B
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 6,574,261$1.8B | +129,405+2.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 5,362,254$1.5B | -13,866−0.3% |
| VICTORY CAPITAL MANAGEMENT INCadded · filed 7 Aug 2026 | 4,837,573$1.4B | +210,447+4.5% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,907,656$1.1B | +44,485+1.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 3,678,798$1.0B | -1,863−0.1% |
| Boston Partnersadded · filed 4 Aug 2026 | 3,051,690$854.2M | +682,894+28.8% |
| Allspring Global Investments Holdings, LLCadded · filed 13 Aug 2026 | 2,236,957$635.0M | +10,511+0.5% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 2,188,890$610.4M | +2,948+0.1% |
| Select Equity Group, L.P.reduced · filed 14 Aug 2026 | 1,981,948$554.9M | -192,837−8.9% |
| FMR LLCadded · filed 13 Aug 2026 | 1,904,870$533.4M | +616,459+47.8% |
31 Mar 2023 – 30 Jun 2026
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.